PMCB
PharmaCyte Biotech Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.69
+0.00 -0.69%
🌙 3월 13일 6:31 PM ET (한국 3/14 07:31)
$0.70
+0.01 ▲ +1.84%
| Index | - | P/E | - | EPS (ttm) | -1.31 | Insider Own | 7.66% | Shs Outstand | 0.01B | Perf Week | -8.34% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 25.98% | Shs Float | 0.01B | Perf Month | -4.79% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 9.71% | Short Float | 1.14% | Perf Quarter | -33.63% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 0.37% | Short Ratio | 0.37 | Perf Half Y | -32.99% |
| Sales | 0.00B | P/B | 0.13 | EPS next 5Y | - | ROA | -12.74% | Short Interest | 0.11M | Perf YTD | -4.67% |
| Book/sh | 5.18 | P/C | 0.45 | EPS past 3/5Y | - | ROE | -17.78% | 52W High | -60.18% ($1.73) | Perf Year | -58.67% |
| Cash/sh | 1.54 | P/FCF | - | Sales past 3/5Y | - | ROIC | -24.84% | 52W Low | 9.56% ($0.63) | Perf 3Y | -76.12% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -340.4% | Gross Margin | - | Volatility(W/M) | 7.49% 8.73% | Perf 5Y | -97.81% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.06 | Perf 10Y | -99.31% |
| Dividend Ex-Date | - | Quick Ratio | 14.6 | EPS Q/Q | -219.7% | Profit Margin | - | RSI (14) | 45.66 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.6 | Sales Q/Q | - | SMA20 | -0.54% ($0.69) | Beta | 0.4 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -11.11% ($0.78) | Rel Volume | 0.11 | Prev Close | $0.69 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -24.87% ($0.92) | Avg Volume(3M) | 0.29M | Price | $0.69 |
| IPO | 2003/9/11 | Option/Short | Yes/Yes | Trades | 73 | Volume | 30,250 | Change | -0.69% |
뉴스 로딩 중...